Omaha, NENCT06672978Now EnrollingIRB Ready

Urinary Tract Infection Clinical Trial in Omaha, NE

Access cutting-edge urinary tract infection treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.

Sponsored by Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)

Quick Self-Assessment

See if you qualify for this Omaha location

Preparing your pre-screening questions...

Expert Care in Omaha

Access urinary tract infection specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related urinary tract infection treatment provided free

Apply for This Omaha Location

Check if you qualify for this urinary tract infection clinical trial in Omaha, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Omaha

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Omaha site if eligible
  4. 4Begin participation

About This Urinary Tract Infection Study in Omaha

The primary objective of the study is to assess the safety and tolerability of meropenem-vaborbactam administered by intravenous (IV) infusion in children 3 months and above to less than 12 years with complicated urinary tract infections (cUTI), including acute pyelonephritis (AP)

Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)

Who Can Participate

Inclusion Criteria

Have a clinically suspected and/or bacteriologically documented cUTI or AP judged by the Investigator to require hospitalization for treatment with at least 3 days of IV antibiotics.
Evidence of pyuria, confirmed by either of the following:
A urine specimen that is positive for leukocyte esterase via urine dipstick or urinalysis, or
A urine specimen with either \> 10 white blood cells (WBCs) per microliter from an unspun urine or \> 5WBCs per high power field from a centrifuged specimen
Symptomatic or asymptomatic cUTI or AP as specified in the protocol.
Acute Pyelonephritis (qualifying symptoms specified in protocol)
Have a pretreatment "baseline" urine specimen obtained for culture by an acceptable method, including suprapubic aspiration (SPA), clean urethral catheterization, in dwelling urethral catheter, or mid-stream clean catch (urine specimens obtained from externally placed urine bags will not be allowed) within 48 hours before the

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Omaha?

Yes, this clinical trial (NCT06672978) has an active research site in Omaha, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Urinary Tract Infection Treatment Options in Omaha, NE

If you're searching for urinary tract infection treatment options in Omaha, NE, this clinical trial (NCT06672978) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced urinary tract infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all urinary tract infection clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Omaha, NE

See all rheumatoid arthritis clinical trials recruiting in Omaha — not just this study.

Browse Rheumatoid Arthritis Trials in Omaha →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsUTI TrialsAll Conditions →

Ready to Join in Omaha?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Omaha, NE